MK
Mahendra Kumar Daga
About Mahendra Kumar Daga
Data last updated:
Mahendra Kumar Daga is a Director at Auro Laboratories Limited (since 2024). The company operates in Pharma. Auro Laboratories Limited reported revenue of ₹20.05 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2024 | 1989 | ₹20.05 Cr (FY 2025) | Active |
Board colleagues of Mahendra Kumar Daga
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kavita Vijayakant Sharma | 07139910 | Auro Laboratories Limited | Director |
| Kiran Suresh Kulkarni | 09175595 | Auro Laboratories Limited | Whole-Time Director |
| Nitesh Kumar Bohra | Auro Laboratories Limited | Cfo | |
| Padma Tapariya | Auro Laboratories Limited | Company Secretary | |
| Sharat Deorah | 00230784 | Auro Laboratories Limited | Managing Director |
| Siddhartha Deorah | 00230796 | Auro Laboratories Limited | Whole-Time Director |
| Vishal Kailashchandra Jhunjhunwala | 00359872 | Auro Laboratories Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahendra Kumar Daga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahendra Kumar Daga
Mahendra Kumar Daga currently holds 1 directorship: Auro Laboratories Limited (Director, since 01 Apr 2024, revenue ₹20.05 Cr (FY 2025)).
Mahendra Kumar Daga was first appointed on 01 Apr 2024 as Director at Auro Laboratories Limited.
The current boards of Mahendra Kumar Daga's companies include Kavita Vijayakant Sharma (Auro Laboratories Limited), Kiran Suresh Kulkarni (Auro Laboratories Limited), Nitesh Kumar Bohra (Auro Laboratories Limited), Padma Tapariya (Auro Laboratories Limited), Sharat Deorah (Auro Laboratories Limited), Siddhartha Deorah (Auro Laboratories Limited), among others.